HOME - Clinical cases - Implantology
 
 
24 February 2023

The inflammatory profile in patients with cardiovascular disease affected by peri-implantitis

Lara Figini


Cardiovascular disease (CVD), the leading cause of mortality worldwide, is an umbrella term to describe a range of clinical heart and circulatory diseases.

Total cardiovascular disease, coined by the American Heart Association and encompassing coronary heart disease, heart failure, stroke and hypertension, has a prevalence of around 48% in adults.

There are several literature studies supporting the independent association between chronic oral infection and different chronic noncommunicable diseases, including CVD.

Materials and methods

In a study published in June 2022 in the Journal of Periodontology, the authors investigated pro-inflammatory cytokine profiles in patients with or without cardiovascular disease (CVD) and with or without peri-implantitis.

Serum, peri-implant crevicular fluid (PICF), and gingival crevicular fluid (GCF) were collected from patients with (n = 82) or without (n = 46) CVD at the site of the most severe peri-implantitis, including sites with periodontitis.

Proinflammatory molecules including high sensitivity C-reactive protein (hsCRP), fibrinogen, interleukin-1 beta (IL-1β), IL-6, plasma tumor necrosis factor-alpha (TNF-α), matrix metalloproteinase 8 (MMP-8), osteoprotegerin (OPG), vascular endothelial growth factor (VEGF), IL-17, IL-8, tissue inhibitor of metalloproteinase-2 (TIMP-2), myeloperoxidase (MPO) and prostaglandin E2 (PGE2 ) were analyzed.

Researchers used the Kruskal-Wallis test to compare the groups. The diagnostic ability of each biomarker was evaluated using the chi-squared test and ROC analysis.

Results

Serum IL-1β, TNF-α, and fibrinogen were significantly higher in patients with CVD than in those without. Serum fibrinogen showed a trend for higher concentration in patients with radiographic bone loss (RBL) ≥2 mm (P = 0.08).

TNF-α in the peri-implant crevicular fluid PICF showed a significantly higher level of detection in CVD patients and this coincides with local peri-implant inflammation. Furthermore, MMP8 in the PICF was significantly higher in sites with radiographic RBL bone loss ≥2 mm than in areas with healthy implants, while IL-1β, IL-8, MMP-8 and TIMP-2 were significant predictors for peri-implant disease.

TNF-α collected in gingival crevicular fluid from patients with periodontitis was significantly associated with CVD cases.

Conclusions

From the data of this study, it can be concluded that the increased expression of local and systemic proinflammatory cytokines found in the present study supports the possible association between chronic peri-implantitis with increasing severity and CVD. However, conclusive evidence is weak.

For more information: "Pro-inflammatory profiles in cardiovascular disease patients with peri-implantitis."

Related articles

Today, implant restorations are the gold standard treatment for eden­tulous patients. However, short and long-term complications can also occur.


Swiss Dental Solutions (SDS), a leading manufacturer of ceramic implants for over a decade, offers implant systems that combine material biocompatibility with established clinical performance. 


The number of people receiving dental implants is increasing annually as more individuals become aware of the advantages of replacing missing teeth.


This week, from March 7th to 9th, the 2024 Annual Meeting of the Academy of Osseointegration (AO) will commence at the Convention Center in Charlotte, North Carolina.


Despite this topic having been debated for years, the evidence for smoking as a risk factor for peri-implantitis still remains inconclusive.


Read more

For a variety of reasons, orthodontic intervention is often overlooked as a viable modality to correct occlusal, axial, rotational, and space discrepancies before undertaking fixed prosthetic...


Congratulations to Ane Poly, D.D.S., M.Sc., Ph.D., a clinical assistant professor in the UF Department of Endodontics, who was recently chosen as the college’s representative to the Council of...


ONEDAYBIOTECH products garner honor as one of the 16th Annual Readers’ Choice Top 25 Implant Products


National leader in oral health integration and equity joins CareQuest Institute executive team.


Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, today announced its plan to reduce the size of its Board of...


 
 
 
 

 
 
 
 

Most popular

 
 

Events